Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway. (Q40176341)
Jump to navigation
Jump to search
scientific article published on February 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway. |
scientific article published on February 2007 |
Statements
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway (English)
Yasui H
Hideshima T
Ikeda H
Vallet S
Okawa Y
Neri P
Podar K
Chauhan D
Richardson PG
Raje N
Carrasco DR
1 February 2007
1 reference